Targeting Rb Mutant Cancers by Inactivating TSC2
Copyright policy )Targeting Rb Mutant Cancers by Inactivating TSC2
Retinoblastoma (Rb), a tumor suppressor gene, is inactivated in many types of cancer. However little is known about how the loss of Rb function can be targeted in cancer therapies. We have identified that inactivation of TSC2 in Rb mutant cancer cells will induce a synergistic cell death. The synergistic cell death is due to an increase in cellular stress including metabolic, ER, and oxidative stress. Therefore, inactivation of TSC2 and chemothereputics that result in induction of cellular stress may be a novel and effective way to treat cancers containing inactivated Rb.
- University of Chicago United States
Tumor Suppressor Proteins, Apoptosis, Genetic Therapy, Models, Biological, Neoplasms, Mutation, Tuberous Sclerosis Complex 2 Protein, Humans, Molecular Targeted Therapy, Genes, Retinoblastoma, RNA, Small Interfering
Tumor Suppressor Proteins, Apoptosis, Genetic Therapy, Models, Biological, Neoplasms, Mutation, Tuberous Sclerosis Complex 2 Protein, Humans, Molecular Targeted Therapy, Genes, Retinoblastoma, RNA, Small Interfering
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).11 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!